当前位置: X-MOL 学术Lancet Global Health › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Point-of-care HPV molecular diagnostics for a test-and-treat model in high-risk HIV populations.
The Lancet Global Health ( IF 19.9 ) Pub Date : 2020-02-01 , DOI: 10.1016/s2214-109x(19)30559-5
Shahin Sayed 1 , Michael Chung 2 , Marleen Temmermans 3
Affiliation  

Strategies for cervical cancer prevention and control in low-income and middle-income countries (LMICs) require concerted efforts to improve screening and access to treatment, especially in high-risk HIV populations. LMICs bear the burden of HIV infection, human papillomavirus (HPV) infection is common among HIV-infected women, risk of cervical cancer is increased in , and HIV clinics provide opportunities to screen and treat for cervical cancer in this population.

中文翻译:

针对高危HIV人群的测试和治疗模型的即时医疗HPV分子诊断。

低收入和中等收入国家(LMIC)的子宫颈癌预防和控制策略需要共同努力,以改善筛查和获得治疗的机会,特别是在高危艾滋病毒人群中。LMIC承受着HIV感染的负担,在HIV感染的女性中人类乳头瘤病毒(HPV)感染是常见的,宫颈癌的患病风险增加,并且HIV诊所为该人群提供了筛查和治疗宫颈癌的机会。
更新日期:2020-01-23
down
wechat
bug